RAAV2-ND4 ( DrugBank: - )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
302	レーベル遺伝性視神経症	2

302. レーベル遺伝性視神経症

---

臨床試験数 : 23 /  薬物数 : 15 - (DrugBank : 5) / 標的遺伝子数 : 5 - 標的パスウェイ数 : 33

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03153293 (ClinicalTrials.gov)	December 27, 2017	10/5/2017	A Single Intravitreal Injection of rAAV2-ND4 for the Treatment of Leber's Hereditary Optic Neuropathy	A Single Intravitreal Injection of rAAV2-ND4 for the Treatment of Leber's Hereditary Optic Neuropathy	Leber Hereditary Optic Neuropathy	Drug: rAAV2-ND4	Huazhong University of Science and Technology	Shiyan Taihe Hospital	Active, not recruiting	10 Years	65 Years	All	159	Phase 2/Phase 3	China
2	NCT01267422 (ClinicalTrials.gov)	April 2011	27/12/2010	Safety and Efficacy Study of rAAV2-ND4 Treatment of Leber Hereditary Optic Neuropathy (LHON)	Safety and Efficacy Study of a Single Intravitreal Injection of rAAV2-ND4 Treatment of Leber Hereditary Optic Neuropathy	Leber Hereditary Optic Neuropathy	Drug: rAAV2-ND4	Bin Li	Huazhong University of Science and Technology	Completed	8 Years	60 Years	All	9	N/A	China